Clostridium difficile infection

Area of Science:

• Microbiology
• Infectious Diseases
• Gastroenterology

Background:

• Clostridium difficile is an anaerobic spore-forming bacterium causing significant enteropathogenic disease.
• Antibiotic-induced alterations in gut microbiota facilitate C. difficile colonization and proliferation in the colon.
• The infection spectrum ranges from asymptomatic carriage to severe conditions like pseudomembranous colitis.

Purpose of the Study:

• To review the clinical presentation, diagnosis, treatment, and prevention of Clostridium difficile infections.
• To highlight the role of toxins A and B in disease pathogenesis.
• To discuss diagnostic modalities and therapeutic strategies, including emerging challenges like antibiotic resistance.

Main Methods:

• Clinical diagnosis based on symptoms (diarrhea) and colonoscopic findings (necrosis, pseudomembranes).
• Laboratory diagnosis utilizing enzyme-linked immunoassays for toxins A/B, cytotoxin assays, fecal leukocytes, fecal lactoferrin, and bacterial culture.
• Molecular diagnostic techniques including polymerase chain reaction (PCR) for toxin B gene detection and DNA-based typing for epidemiology.

Main Results:

• Enzyme-linked immunoassays offer high specificity for toxin detection, though sensitivity may vary compared to cell culture assays.
• Culture for C. difficile is essential for epidemiological studies but is time-consuming.
• PCR-based methods show promise for direct detection of toxigenic C. difficile in stool samples.

Conclusions:

• Effective management involves discontinuing inciting antibiotics and administering oral metronidazole or vancomycin.
• Relapse rates can be high, and increasing vancomycin resistance in Enterococcus poses a concern.
• Prevention of nosocomial spread necessitates strict isolation protocols and rigorous hand hygiene practices.